Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension

Phase

Condition

Liver Disease

Stress

Diabetes And Hypertension

Treatment

N/A

Clinical Study ID

NCT02975323

20-2605/R&D/HEC/12

Ages 17-70
All Genders

Study Summary

Portal hypertension is the result of an increased hepatic vascular resistance and portal inflow. The best established method to assess portal pressures is the determination of wedged hepatic venous pressure gradient (HVPG). Ultrasound Doppler technique is non-invasive in the assessment of portal hypertension as compared with invasive technique of measurement of the hepatic venous pressure gradient (HVPG). Hemodynamic measurements (BP and pulse recording) will be done and then patient will be given tablet Carvedilol 12.5 mg in a single dose and wait till the time that 20% reduction in heart rate from the baseline occurs. Haemodynamic measurements will be repeated to assess the acute response to beta-adrenoreceptor blocker agent. The change in the HWF will be recorded post beta-adrenoreceptor blocker administration.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Patients with cirrhosis and large varices (≥ 5mm) on screening endoscopy
Not known esophageal or gastric variceal bleed

Exclusion

Exclusion Criteria:

Small esophageal varices (<5 mm in size) on screening endoscopy
Hemodynamically unstable i.e. Blood pressure of <90mmHg and tachycardia of >100bpm.
Contraindication to Beta-blockers (Asthma, bradycardia, heart failure, allergy)
history of Esophageal or gastric variceal bleed in the past
Hepatocellular carcinoma or other metastatic malignancy.
Portal vein thrombosis (PVT) or Inferior venacaval (IVC) thrombosis
Congestive cardiac failure (CCF)
Renal failure or Hepatorenal syndrome (Creatine of >1.5 mg/dl)
Previous allergy to IV contrast agent.
Lactating or Pregnant women

Study Design

December 01, 2014

December 31, 2018

Study Description

Ultrasound Doppler technique is non-invasive in the assessment of portal hypertension as compared with invasive technique of measurement of the hepatic venous pressure gradient (HVPG). The Doppler waveform of the hepatic vein in healthy subjects is normally triphasic (two negative waves and one positive wave) because of central venous pressure variations due to the cardiac cycle. The normal triphasic hepatic vein waveform is transformed into a biphasic or monophasic waveform in patients with cirrhosis. A monophasic waveform has been shown to correlate with a high Child-Pugh score and a poor survival rate.

Therefore, Hepatic vein waveform (HVWF) evaluation with Doppler US may be used as a supplemental tool to assess the severity of Portal Hypertension and therapeutic response to portal pressure lowering drugs in primary prophylaxis of variceal bleed in patients with large oesophageal varices. There's one study which has looked into the same topic but it has been conducted on alcoholic cirrhotics.

Doppler ultrasound is a non-invasive tool in the measurement of portal pressure in portal hypertensive patients. Hemodynamic measurements (BP and pulse recording) will be done and then patient will be given tablet Carvedilol 12.5 mg in a single dose and wait till the time that 20% reduction in heart rate from the baseline occurs. Haemodynamic measurements will be repeated to assess the acute response to beta-adrenoreceptor blocker agent. The change in the HWF will be recorded post beta-adrenoreceptor blocker administration. This study will be a validation and interventional study. It is an open labeled study.

Connect with a study center

Aga Khan University,
Karachi, Sind 74800
Pakistan
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.